Back to News
Market Impact: 0.25

Noteworthy Wednesday Option Activity: TMO, MRNA, AES

MRNAAESTMOIDYANDAQ
Futures & OptionsDerivatives & VolatilityMarket Technicals & FlowsInvestor Sentiment & Positioning
Noteworthy Wednesday Option Activity: TMO, MRNA, AES

Moderna (MRNA) and AES Corp (AES) experienced significant options trading activity today, with MRNA's volume at 126,636 contracts (102.8% of its average daily stock volume) and AES's at 82,561 contracts (87.6% of its average daily stock volume). Elevated interest was particularly noted in long-dated call options, specifically MRNA's $25 strike and AES's $16 strike expiring October 2025, suggesting increased speculative positioning or bullish outlooks for both equities.

Analysis

Moderna (MRNA) and AES Corp (AES) are experiencing exceptionally high options market activity, indicating significant investor positioning. MRNA's options volume reached 126,636 contracts, equivalent to 102.8% of its average daily share volume, while AES saw options volume of 82,561 contracts, representing 87.6% of its typical share turnover. The activity in both names is heavily concentrated in long-dated call options expiring in October 2025. Specifically, MRNA's $25 strike call traded 16,385 contracts, and AES's $16 strike call traded 5,800 contracts. This targeted, long-term bullish positioning suggests that traders are speculating on substantial price appreciation over the next two years, potentially in anticipation of specific company catalysts. The fact that options volume rivals or exceeds underlying stock volume signifies that the derivatives market is a primary venue for expressing views on these equities.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

Ticker Sentiment

AES0.00
IDYA0.00
MRNA0.00
NDAQ0.00
TMO0.00

Key Decisions for Investors

  • Monitor the open interest and volume trends in the specified October 2025 call options for MRNA ($25 strike) and AES ($16 strike) as a leading indicator of institutional conviction and potential future price targets.
  • Investors should investigate potential long-term catalysts for both companies that could justify the bullish positioning, such as MRNA's product pipeline or AES's energy transition strategy, to validate the thesis implied by the options flow.
  • Given that high options volume can precede increased stock volatility, consider reviewing risk management strategies for existing equity positions in MRNA and AES.